Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? Why are drugmakers spending so much money on acquisitions? And are hair loss drugs a good investment?
Elaine Chen is a national biotech reporter at STAT and co-writes The Readout newsletter. She covers a range of topics related to medicine and healthcare, with a focus on pharmaceuticals, public health, and the intersection of AI and healthcare. Elaine's work has been featured in prominent publications including BioRxiv, Yahoo Finance, Bloomberg News, and The New York Times.












